Senior insider sale
General Counsel at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$502.3K
1.05K shares
What this filing means
KELLEY SHANNON T plans to sell 1.05K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $502.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/6/2026ACC: 0001628280-26-015760
Officer· General Counsel
Since Mar 2026
1.05K
Shares to sell
$502.3K
Approx. market value
360.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
3/5/2026
360.00Total acquired360.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/5/2026 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 360.00 | — |
| Total | 360.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
429.00
Market value
$215.1K
1/20/2026
—Completed
Units to sell
263.00
Market value
$129.1K
1/20/2026
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
360.00
Market value
$158.2K
3/6/2026
Total
Units
1.05K
Value
$502.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/20/2026 | 429.00 | $215.1K | — | Completed |
1/20/2026 | 263.00 | $129.1K | — | Completed |
| Planned — Approximate Date | ||||
3/6/2026 | 360.00 | $158.2K | Nasdaq Stock Market | Planned |
| Total | 1.05K | $502.3K | ||